New EPGL Tweets -> EPGL is back on Twitter! Next stop:

New Post Public Reply Private Reply Replies (1) Message Board
Vikingzskillz
New EPGL Tweets -> EPGL is back on Twitter! Next stop: Leading Consumer Electronics Giants. Closing in on our next deal!

It can be revealed that EPGL has had phone conversations with Apple Intellectual Property counsel over past several weeks. We are also engaging with other consumer electronics companies and social media for development of our MEMS technologies. We will keep our appreciated shareholders informed as we progress on these new frontiers. Don't listen to uninformed anonymous people on public forums for your investment advice. Irrational and volatile moves in your portfolio can result. Have a wonderful weekend.

In answer to some interested shareholders; no restricted shares of major EPGL beneficial shareholders have had restrictive legend removed to date and there are no plans to do so. The beneficial shareholders are focused on raising overall company and shareholder value...In addition, there will never be another reverse split. We believe that recent highs of share price are indicative of EPGL strength in the market based on real, tangible developments happening now, in real-time. We believe those recent highs can and will be surpassed.

Team EPGL is quickly becoming recognized as an industry leader in the most innovative new MEMS technologies by other very large companies..and YES EPGL is already on multiple new filings of new intellectual property jointly, with other industry leading companies.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading